Schizophrenia is a significant psychopathology characterized by symptoms such as hallucinations, delusions, distorted thought processes, and emotional flatness. Symptoms: Positive symptoms include hallucinations (hearing or seeing things that are not there), delusions (false beliefs), and disorganized thought processes, such as bouncing from one issue to another. Negative symptoms are those that indicate a decline in normal functioning, such as emotional numbness, a lack of drive, and social isolation. Antipsychotic medicines are the most often used pharmacological therapy for schizophrenia. These drugs function by inhibiting dopamine receptors in the brain, so reducing the excessive dopamine activity believed to contribute to the positive symptoms of schizophrenia. Typical antipsychotics (such as chlorpromazine and haloperidol) and atypical antipsychotics are the most often used antipsychotic medicines (such as clozapine, risperidone, and olanzapine) Types of neurotransmitters/hormones and receptors that are specific: Dopamine is a neurotransmitter believed to contribute to the positive symptoms of schizophrenia, including hallucinations and delusions. Antipsychotic drugs target dopamine receptors in the brain to lessen the excessive dopamine activity that is believed to contribute to these symptoms. Glutamate is a neurotransmitter believed to contribute to the negative symptoms of schizophrenia, including emotional flatness and lack of desire. Recent study reveals that the glutamate system in the brain may be targeted by some atypical antipsychotic drugs. Schizophrenia is a complicated condition with various origins that is believed to be impacted by both hereditary and environmental factors. According to twin studies, the heredity of schizophrenia is around 80%. Recent study has revealed numerous genes associated with the dopamine and glutamate neurotransmitter systems that may enhance the chance of developing schizophrenia. Neuroimaging and other data about brain variations/mechanisms: Studies of structural brain imaging have shown that patients with schizophrenia have an atypical brain structure, including a smaller brain volume and less gray matter in particular brain areas, including the prefrontal cortex, temporal lobes, and hippocampus. The prefrontal cortex, temporal lobes, and hippocampus, which are involved in cognitive functions such as attention, memory, and emotion, exhibit aberrant brain activity in patients with schizophrenia, according to functional neuroimaging studies. In addition, studies have shown that persons with schizophrenia have aberrant connection between several brain areas, which may contribute to the disorder's symptoms. Schizophrenia is a complicated condition marked by hallucinations, delusions, abnormal thinking, and emotional flatness. Researchers have found many genes that may raise the chance of getting the illness, which is believed to be caused by hereditary and environmental factors. Antipsychotic medicine is the main therapy for schizophrenia; it works by inhibiting dopamine receptors in the brain. Brain imaging studies have shown that patients with schizophrenia have aberrant brain structure and activity in certain brain areas, as well as improper connection between brain regions, which may contribute to the disorder's symptoms. 